期刊文献+

糖尿病及其血管并发症的介入治疗 被引量:2

下载PDF
导出
摘要 糖尿病(diabetes mellitus,DM)根据发病机制的不同,可分为1型和2型.糖尿病介入治疗主要是针对1型DM由于胰岛β细胞缺乏造成胰岛素分泌绝对不足进行胰岛β细胞或者干细胞移植,从而增加胰岛素分泌的绝对量达到治疗DM的目的.DM的血管并发症介入治疗,最常见的是糖尿病足的治疗,使用经皮经腔血管成形术(percutaneous transluminal angioplasty,PTA)和血管内支架为糖尿病足及其他周围血管病变提供了一个新的治疗途径.
出处 《世界华人消化杂志》 CAS 北大核心 2006年第21期2112-2115,共4页 World Chinese Journal of Digestology
基金 上海市科技发展基金资助课题.No.044119721
  • 相关文献

参考文献23

  • 1谢平,穆会君,徐卓群,徐汇义,张滨,张稷,诸明,阮钧,蔡兵,吴鸣宇.成人胰岛细胞的分离纯化及初步的临床应用[J].中华器官移植杂志,2005,26(6):350-352. 被引量:5
  • 2Maleux G,Gillard P,Keymeulen B,Pipeleers D,Ling Z,Heye S,Thijs M,Mathieu C,Marchal G.Feasibility,safety,and efficacy of percutaneous transhepatic injection of beta-cell grafts.J Vasc Interv Radiol ,2005; 16:1693-1697
  • 3Osama Gaber A,Chamsuddin A,Fraga D,Fisher J,Lo A.Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation.Transplantation ,2004; 77:309-311
  • 4Antonello P,Rodoifo A,Camillo R.Islet transplantation:steady progress and current challenges.Current Opinion in Organ Transplantation ,2006; 11:7-13
  • 5李永翔,谭建明.胰腺移植及胰岛移植的现状[J].国外医学(移植与血液净化分册),2005,3(1):29-31. 被引量:4
  • 6胡礼炳,徐卓群.胰岛细胞移植的临床免疫问题[J].国外医学(移植与血液净化分册),2005,3(1):32-35. 被引量:1
  • 7Shapiro AM,Lakey JR,Ryan EA,Korbutt GS,Toth E,Warnock GL,Kneteman NM,Rajotte RV.Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med ,2000;343:230-238
  • 8李涛,杜智,孙铭,周道标,孙以鲁,宋继昌,孙绵方.APA微囊猪胰岛的实验研究[J].中国生物医学工程学报,2005,24(4):507-509. 被引量:6
  • 9Zwillich T.Diabetes research.Islet transplants not yet ready for prime time.Science ,2000; 289:531-533
  • 10金建,郑景晨.胰腺干细胞移植研究进展[J].医学综述,2005,11(11):1012-1013. 被引量:3

二级参考文献55

  • 1MagaliJ.Fontaine.Islet cell transplantation as a cure for insulin dependent diabetes: current improvements in preserving islet cell mass and function[J].Hepatobiliary & Pancreatic Diseases International,2003,2(2):486-495. 被引量:11
  • 2龚家镇.胰岛移植现状[J].普外临床,1996,11(2):116-118. 被引量:7
  • 3李涛,宋继昌,杜智,杨江山,孙铭,高茹,崔润海,孙绵方.大鼠和猪胰岛分离、纯化、包埋的研究[J].普外临床,1997,12(2):113-115. 被引量:2
  • 4lanus A, Holz GG. Theise ND, et al. in vivo derivation of glucose competent pancreatic endocrine cells from bone marrow without evidence of cell fusion[ J]. J Clin Invest. 2003. 111: 799- 801.
  • 5Okumura K, Nakamura K, Hisatomi Y, et al. Salivary gland progenitor cells induced by duct ligation differentiate into hepatic andpancreatic lineages[ J]. Hepatology, 2003, 38: 104- 113.
  • 6Choi JB, UchinoH, Azuma K, et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells[ J]. Diabetologia, 2003, 46: 1366- 1374.
  • 7YingQL, Nichols J, Evans EP, et al. Changing potency by spontaneous fusion [J]. Nature, 2002, 416: 545- 548.
  • 8Kahan BW, Jacobson LM,Hullett DA. el al.pancreatic precursors and differntiated islet cell types from murine embryonic stem cells an in vitro model to study islet differentiation[j]. Diabetes.2003.52:2016-2024
  • 9Assady S, Maor G, Amit M, et al. Insulin production by human embryonic stem cells[ J]. Diabetes, 2000, 50: 1691- 1697.
  • 10Soria B, Roche E, Leon-QumtoT, et al. Insulin-secreting cells derived from embryonic stem cells nonnalize glycem ia in streptozotoc in-induced diabetic mice[J]. Diabetes, 2000, 49: 157-162.

共引文献32

同被引文献5

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部